Target intelligence / Profile preview

Cofactor-dependent metabolic enzyme

Molecular classification
Enzyme
01

Overview

Cofactor-dependent metabolic enzymes are a broad class of proteins that require non-protein chemical components, known as cofactors, to perform their biological functions (Source [1], [2]). These cofactors include metal ions and complex organic molecules, many of which are derived from essential vitamins such as thiamine (B1), riboflavin (B2), and pyridoxine (B6) (Source [3], [4]). Cofactors can be broadly categorized into essential metal ions and organic coenzymes, which may be tightly bound prosthetic groups or loosely associated cosubstrates (Source [2]). These enzymes are integral to central metabolic pathways, including the citric acid cycle, glycolysis, and the metabolism of amino acids and fatty acids. Dysregulation or mutation of these enzymes is linked to various diseases; for example, mutations in isocitrate dehydrogenase (IDH1/2) lead to the production of the oncometabolite 2-hydroxyglutarate in certain cancers (Source [1]). Therapeutic targeting of these enzymes often involves small molecules that compete with the cofactor or substrate, or drugs like isoniazid and phenelzine that interact with specific cofactor-dependent mechanisms (Source [1]). Because these enzymes are essential for normal cellular homeostasis, pharmacological intervention requires careful management to avoid systemic toxicity or secondary metabolic deficiencies (Source [3]).

Other names
Coenzyme-dependent enzymesHoloenzymesVitamin-dependent enzymesCofactor-requiring enzymes
02

Mechanism of action

Drugs targeting these enzymes typically act through competitive inhibition of the cofactor or substrate binding sites, or via covalent modification of the cofactor itself (e.g., hydrazine-based inhibitors) (Source [1]).

03

Biological functions

MetabolismRedox reactionCatalysisEnergy productionBiosynthesis
04

Disease associations

CancerMetabolic diseaseInfectionNeurodegenerative diseaseVitamin deficiency
05

Safety considerations

Systemic metabolic toxicitySecondary vitamin depletionOff-target effects due to cofactor ubiquityNeurotoxicity associated with vitamin B6 antagonism
06

Interacting drugs

Isoniazid

9 more in the full profile.

07

Biomarkers

2-hydroxyglutarate (2-HG)LactateHomocysteineSerum vitamin levelsEnzyme activity assays

Beyond the preview

Go deeper on Cofactor-dependent metabolic enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cofactor-dependent metabolic enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call